1. Home
  2. CPT vs ALGN Comparison

CPT vs ALGN Comparison

Compare CPT & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden Property Trust

CPT

Camden Property Trust

HOLD

Current Price

$104.40

Market Cap

10.9B

Sector

Real Estate

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPT
ALGN
Founded
1993
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
10.2B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
CPT
ALGN
Price
$104.40
$157.47
Analyst Decision
Buy
Buy
Analyst Count
19
13
Target Price
$119.78
$190.50
AVG Volume (30 Days)
1.5M
1.5M
Earning Date
11-06-2025
10-29-2025
Dividend Yield
4.02%
N/A
EPS Growth
N/A
N/A
EPS
2.47
5.16
Revenue
$1,578,428,000.00
$3,982,622,000.00
Revenue This Year
$2.48
$2.58
Revenue Next Year
$1.94
$3.41
P/E Ratio
$42.24
$30.46
Revenue Growth
1.41
0.56
52 Week Low
$97.17
$122.00
52 Week High
$126.55
$246.19

Technical Indicators

Market Signals
Indicator
CPT
ALGN
Relative Strength Index (RSI) 49.09 73.38
Support Level $105.68 $144.00
Resistance Level $106.77 $152.99
Average True Range (ATR) 1.51 4.97
MACD 0.07 1.74
Stochastic Oscillator 43.34 92.40

Price Performance

Historical Comparison
CPT
ALGN

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: